ITGAX and neoplasm: Importantly, we discovered that ICAM1 binding to the ITGAX/ITGB2 heterodimer facilitates neutrophil-monocyte crosstalk, skewing monocyte differentiation toward pro-tumor TAMs and fostering tumorigenesis (63, 64).